The Valley Desk

NCT02855359 · Interventional trial

Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

Overall registry status Terminated

Phase 2

Conditions Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCL

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov